DexCom (NASDAQ: DXCM)
DexCom Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
DexCom Company Info
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.
News & Analysis
1 Growth Stock Down 40% to Buy Hand Over Fist Right Now
It is dealing with some short-term issues, but its prospects remain bright.
If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today
The company's innovative devices have helped it generate decent performances.
DexCom (DXCM) Q2 Revenue Jumps 15%
Why This Beaten-Down Medical Device Stock Could Be Your Best Investment for the Next 5 Years
Investing in Internet of Things Stocks
Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next
DexCom: Revenue Up, EPS Misses Mark
DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short.
Should You Buy DexCom Stock Before Feb. 13?
Valuation
Earnings Transcripts
DexCom (DXCM) Q4 2024 Earnings Call Transcript
DXCM earnings call for the period ending December 31, 2024.
DexCom (DXCM) Q3 2024 Earnings Call Transcript
DXCM earnings call for the period ending September 30, 2024.
DexCom (DXCM) Q2 2024 Earnings Call Transcript
DXCM earnings call for the period ending June 30, 2024.
DexCom (DXCM) Q1 2024 Earnings Call Transcript
DXCM earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.